• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NasdaqGM
    4.14 Up 0.03(0.73%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:4.11
    Open:4.28
    Bid:3.67 x 500
    Ask:4.60 x 4000
    1y Target Est:4.90
    Beta:3.77
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:4.11 - 4.30
    52wk Range:2.96 - 11.65
    Volume:404,320
    Avg Vol (3m):635,536
    Market Cap:183.55M
    P/E (ttm):N/A
    EPS (ttm):-0.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACRX

    Comparison

    Symbol% ChgMkt Cap
    ACRXUp 0.73%183.55M
    BAXDown 1.44%20.82B
    HSPUp 0.07%15.37B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):34.36
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.70
    Quarterly EPS Est (Jun-15) :-0.24
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. The company’s lead product candidate is Zalviso, an investigational, pre-programmed, non-invasive, handhe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback